Nobuyoshi Maeji - Anteo Diagnostics Insider

Anteo Diagnostics Limited -- Australia Stock  

AUD 0.015  0.001  7.14%

Chief Scientific Officer

Dr. Nobuyoshi Joe Maeji, Ph.D., is Founder, Chief Scientific Officer of Anteo Diagnostics Limited. Dr. Joe Maeji is the founder of BioLayer. Prior to forming Bio Layer, Dr. Maeji held the position of Head of Research for Mimotopes Pty Ltd and Sr. Director for Small Molecule Drug Discovery for Chiron. At Mimotopes Pty Ltd., he directed RD, production as well as commercialization of products and technologies during the growth of this company
  Executive Since 2009  Ph.D    
61 7 3219 0085
Maeji holds a Ph.D. in Polymer Engineering from the Tokyo Institute of Technology.

Management Efficiency

The company has return on total asset (ROA) of (2.66) % which means that it has lost $2.66 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (68.77) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 697.44 K in total debt with debt to equity ratio (D/E) of 11.7 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Anteo Diagnostics Limited has Current Ratio of 1.15 suggesting that it is in a questionable position to pay out its financial obligations in time and when they become due.

Similar Executives

Showing few of many executives


Bold BaatarRio Tinto Limited
Rachel AgnewBHP Billiton Limited
Alden ToevsCommonwealth Bank of Australia
Vittoria ShorttCommonwealth Bank of Australia
Maile CarnegieAustralia and New Zealand Banki
Alfredo BarriosRio Tinto Limited
Debra ValentineRio Tinto Limited
Adam BennettCommonwealth Bank of Australia
Alexandra HolcombWestpac Banking Corporation
Andrew BowdenWestpac Banking Corporation
Steve AllenRio Tinto Limited
Rebecca LimWestpac Banking Corporation
Megan PepperBHP Billiton Limited
Alfredo PrietoRio Tinto Limited
John PriestleyAustralia and New Zealand Banki
Stephen McIntoshRio Tinto Limited
Alan DaviesRio Tinto Limited
David StephenWestpac Banking Corporation
Michael LiarakosAustralia and New Zealand Banki
Andrew CuthbertsonCSL Limited
Hugo BagueRio Tinto Limited

Entity Summary

Anteo Diagnostics Limited engages in developing, commercializing, manufacturing, and distributing products for the life sciences, clinical diagnostics, and bioseparations markets. Anteo Diagnostics Limited is based in Eight Mile Plains, Australia. Anteo Diagnostics is traded on Australian Securities Exchange in Australia.Anteo Diagnostics Limited (ADO) is traded on Australian Securities Exchange in Australia. It is located in 4/26 Brandl Street and employs 99 people.

Did you try this?

Run CEO Directory Now

CEO Directory

Screen CEOs from public companies around the world
Hide  View All  NextLaunch CEO Directory
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Anteo Diagnostics Limited to your portfolio

Top Management

Anteo Diagnostics Limited Leadership Team
Nobuyoshi Maeji, Executive, Ph.D
Alan Studley, Director, CPA
Mark Bouris, Chairman
Peter HardingSmith, CFO
Matthew Sanderson, Director
John Hurrell, Director, Ph.D
Stefan Enderling, CEO, Ph.D
Geoffrey Cumming, CEO
Tamara Mills, COO
Julien McInally, Executive, CPA
Shane Hartwig, Executive
Nevin Abernethy, Executive
Richard Martin, Director
Jef Vangenechten, CEO, Ph.D
Rolf Sickman, Director
Sandra Andersen, Director, CPA

Stock Performance

Anteo Diagnostics Performance Indicators